Nomura Holdings’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Nomura Holdings’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-38,177	Closed	-$5.62M	–	2022
2022 Q3	$5.62M	Buy	38,177 +35,837	+1,531%	+$5.31M	0.02%	513
2022 Q2	$332K	Buy	2,340 +1,340	+134%	+$171K	﹤0.01%	1204
2022 Q1	$117K	Sell	1,000 -8,601	-90%	-$1.07M	﹤0.01%	1665
2021 Q4	$1.29M	Buy	+9,601	New	+$1.22M	﹤0.01%	1133
2021 Q1	–	Sell	-17,500	Closed	-$1.5M	–	2424
2020 Q4	$1.5M	Buy	+17,500	New	+$1.48M	﹤0.01%	923
2020 Q1	–	Sell	-5,000	Closed	-$272K	–	1365
2019 Q4	$272K	Hold	5,000	–	–	﹤0.01%	982
2019 Q3	$207K	Hold	5,000	–	–	﹤0.01%	1083
2019 Q2	$216K	Buy	+5,000	New	+$282K	﹤0.01%	1028

Other funds holding BHVN

LIP

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Nomura Holdings's BHVN Position: Q4 2022 in Review

Nomura Holdings sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 38,177 shares — an estimated $5.62M sold.

Nomura Holdings first reported a position in BHVN in Q2 2019 and held it in 8 quarters. The position peaked at $5.62M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

Nomura Holdings reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
Nomura Holdings sold 38,177 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $5.62M.
Nomura Holdings first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 8 quarters.
Nomura Holdings's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $5.62M in Q3 2022.
7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Nomura Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.